These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 4736097)

  • 21. [Postpartal lactation inhibition by 2-Br-alpha-ergocryptine: I. A comparative study with 2-Br-alpha-ergocryptine in different dosages and placebo (author's transl)].
    Varga L; Radielovic P
    Geburtshilfe Frauenheilkd; 1974 Oct; 34(10):882-4. PubMed ID: 4613600
    [No Abstract]   [Full Text] [Related]  

  • 22. Proceedings: The luteotrophic and lactogenic activities of prolactin, human chorionic somatomammotrophin and mouse placental extract on mice treated with an ergocornine derivative.
    Zumpe N; Blake M; Wilson CA
    J Endocrinol; 1974 May; 61(2):LXX. PubMed ID: 4857925
    [No Abstract]   [Full Text] [Related]  

  • 23. Inhibition of lactation and prolactin secretion in rats by ergot alkaloids.
    Shaar CJ; Clemens JA
    Endocrinology; 1972 Jan; 90(1):285-8. PubMed ID: 5009064
    [No Abstract]   [Full Text] [Related]  

  • 24. Interference with prolactin release and the maternal behavior of female rats.
    Numan M; Leon M; Moltz H
    Horm Behav; 1972 Mar; 3(1):29-38. PubMed ID: 4680505
    [No Abstract]   [Full Text] [Related]  

  • 25. Inhibition of DMBA-induced mammary carcinogenesis in the rat by 2-br- -ergocryptine (CB 154), an inhibitor of prolactin secretion, and by nafoxidine (U-11, 100 A), an estrogen antagonist.
    Heuson JC; Waelbroeck C; Legros N; Gallez G; Robyn C; L'Hermite M
    Gynecol Invest; 1971; 2(1):130-7. PubMed ID: 5170652
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment of galactorrhea-amenorrhea syndrome with Br-ergocryptine (CB 154): restoration of ovulatory function and fertility.
    Varga L; Wenner R; Del Pozo E
    Am J Obstet Gynecol; 1973 Sep; 117(1):75-9. PubMed ID: 4722381
    [No Abstract]   [Full Text] [Related]  

  • 27. Bovine serum prolactin, growth hormone, cortisol and milk yield after ergocryptine.
    Smith VG; Beck TW; Convey EM; Tucker HA
    Neuroendocrinology; 1974; 15(3-4):172-81. PubMed ID: 4472947
    [No Abstract]   [Full Text] [Related]  

  • 28. Suppression of puerperal lactation with an ergot alkaloid: a double-blind study.
    Varga L; Lutterbeck PM; Pryor JS; Wenner R; Erb H
    Br Med J; 1972 Jun; 2(5816):743-4. PubMed ID: 4556543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypothalamic control of prolactin secretion.
    Meites J; Clemens JA
    Vitam Horm; 1972; 30():165-221. PubMed ID: 4565620
    [No Abstract]   [Full Text] [Related]  

  • 30. Inhibition of cyclic gonadotropin secretion by endogenous human prolactin.
    Tyson JE; Khojandi M; Huth J; Smith B; Thomas P
    Am J Obstet Gynecol; 1975 Feb; 121(3):375-9. PubMed ID: 1115151
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of ergot alkaloids on pregnancy and lactation in the albino rat.
    SOMMER AF; BUCHANAN AR
    Am J Physiol; 1955 Feb; 180(2):296-300. PubMed ID: 14361726
    [No Abstract]   [Full Text] [Related]  

  • 32. [Analogue drugs of ergot-alkaloids with an inhibitory effect upon prolactin secretion and their influence upon the mammary gland (author's transl)].
    Rezábek K; Ausková M; Semonský M
    Cesk Gynekol; 1975 Feb; 40(1):52-3. PubMed ID: 1131904
    [No Abstract]   [Full Text] [Related]  

  • 33. Mammotropic effect of prolactin enhanced by thyroidectomy.
    Mittra I
    Nature; 1974 Apr; 248(448):525-6. PubMed ID: 4824351
    [No Abstract]   [Full Text] [Related]  

  • 34. Proceedings: CB 154 (2-bromo-alpha-ergokryptine, bromocriptin), a potential anti-Parkinson agent.
    Johnson AM; Vigouret JM; Loew DM
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R40. PubMed ID: 4276573
    [No Abstract]   [Full Text] [Related]  

  • 35. Control of prolactin secretion in man.
    Bohnet HG; Friesen HG
    Curr Top Mol Endocrinol; 1976; 3():257-81. PubMed ID: 802654
    [No Abstract]   [Full Text] [Related]  

  • 36. Inhibition of mammary tumorigenesis by ergot alkaloids and promotion of mammary tumorigenesis by pituitary isografts in adreno-ovariectomized mice.
    Yanai R; Nagasawa H
    J Natl Cancer Inst; 1972 Mar; 48(3):715-9. PubMed ID: 5058970
    [No Abstract]   [Full Text] [Related]  

  • 37. Two-bromo- -ergocryptine (CB 154) inhibition of prolactin secretion and galactorrhoea in a case of pituitary tumour.
    Copinschi G; L'Hermite M; Pasteels JL; Robyn C
    Gynecol Invest; 1971; 2(1):128-9. PubMed ID: 5170651
    [No Abstract]   [Full Text] [Related]  

  • 38. An ergocryptine as a lactation inhibitor.
    Falzon MD; Galea R; Cmailleri AP
    Gynecol Invest; 1974; 5(3):133-8. PubMed ID: 4615051
    [No Abstract]   [Full Text] [Related]  

  • 39. [Inhibition of puerperal lactation with ergot alkaloids].
    Varga L; Luttierbeck PM; Pryor JS; Wenner R; Erb H
    Schweiz Med Wochenschr; 1972 Sep; 102(36):1284-5. PubMed ID: 5054638
    [No Abstract]   [Full Text] [Related]  

  • 40. [Prevention of lactation with a new ergot derivative, CB-154. Comparison with ablacton].
    Mendes ML
    Brux Med; 1974 Dec; 54(12):737-41. PubMed ID: 4474051
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.